Pfizer, Astellas Expand PADCEV-Keytruda Label With FDA Nod In Bladder Cancer

기사 요약

FDA approves Pfizer and Astellas' PADCEV plus Keytruda for muscle-invasive bladder cancer, backed by Phase 3 survival data.